Skip to main content
SpringerLink
Log in

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia case fatalities

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lane S, et al. Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data Drug Safety : 8 Aug 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01217-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia case fatalities. Reactions Weekly 1919, 7 (2022). https://doi.org/10.1007/s40278-022-20949-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20949-0

Search

Navigation